Blend Labs (NYSE:BLND) Insider Sells $71,750.00 in Stock

Key Points

• Insider Selling: Blend Labs insider Brian Kneafsey sold 25,000 shares for $71,750 at an average price of $2.87, reducing his ownership by 3.46%.
• Recent Earnings Report: The company reported a loss of $0.03 EPS, missing estimates of $0.02, with revenues of $31.52 million, below expectations of $31.93 million.
• Analyst Ratings: Blend Labs has received mixed ratings from analysts, with price targets ranging from $3.50 to $7.00 and a consensus rating of "Moderate Buy."

Blend Labs, Inc. (NYSE:BLND - Get Free Report) insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $2.87, for a total value of $71,750.00. Following the transaction, the insider directly owned 696,598 shares in the company, valued at approximately $1,999,236.26. The trade was a 3.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Brian Kneafsey also recently made the following trade(s):

• On Tuesday, July 15th, Brian Kneafsey sold 25,000 shares of Blend Labs stock. The shares were sold at an average price of $3.63, for a total value of $90,750.00.
• On Monday, July 14th, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The shares were sold at an average price of $3.42, for a total value of $68,400.00.
• On Monday, July 7th, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The shares were sold at an average price of $3.46, for a total value of $69,200.00.
• On Monday, June 30th, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The stock was sold at an average price of $3.31, for a total value of $66,200.00.
• On Monday, June 23rd, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The stock was sold at an average price of $3.17, for a total value of $63,400.00.

Blend Labs Stock Performance

Blend Labs stock traded down $0.0350 during mid-day trading on Tuesday, reaching $3.0150. 3,152,651 shares of the company were exchanged, compared to its average volume of 2,721,008. The business has a fifty day moving average of $3.35 and a 200 day moving average of $3.44. The firm has a market cap of $782.87 million, a P/E ratio of -20.10 and a beta of 1.24. Blend Labs, Inc. has a 12-month low of $2.63 and a 12-month high of $5.53.

Blend Labs (NYSE:BLND - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.05). The firm had revenue of $31.52 million during the quarter, compared to analyst estimates of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. Sell-side analysts predict that Blend Labs, Inc. will post -0.19 EPS for the current year.

Institutional Investors Weigh In On Blend Labs

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BLND. Captrust Financial Advisors acquired a new position in shares of Blend Labs in the second quarter valued at approximately $35,000. Merit Financial Group LLC purchased a new position in Blend Labs during the first quarter worth $36,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Blend Labs during the second quarter worth $37,000. Jump Financial LLC purchased a new position in shares of Blend Labs in the 2nd quarter worth $38,000. Finally, Quadrature Capital Ltd purchased a new position in Blend Labs in the second quarter valued at approximately $40,000. Hedge funds and other institutional investors own 52.56% of the company's stock.

Analyst Upgrades and Downgrades

BLND has been the subject of a number of recent analyst reports. UBS Group cut their price objective on shares of Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a report on Friday, August 8th. The Goldman Sachs Group decreased their price target on shares of Blend Labs from $5.60 to $4.80 and set a "buy" rating on the stock in a research note on Monday, May 12th. Wall Street Zen upgraded shares of Blend Labs from a "sell" rating to a "hold" rating in a research report on Sunday. Keefe, Bruyette & Woods cut their price objective on shares of Blend Labs from $4.00 to $3.75 and set a "market perform" rating for the company in a research report on Friday, August 8th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $7.00 target price on shares of Blend Labs in a research note on Wednesday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Blend Labs presently has a consensus rating of "Moderate Buy" and an average target price of $4.88.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.